Technology Platforms
Caremo has established drug R&D technology platforms based on shared and public mechanisms
CMC Technology Platform
Caremo is a comprehensive pharmaceutical R&D service provider that leverages core technologies to integrate the entire lifecycle of "generic drugs + innovative drugs" development and industrialization. Adopting a dual-driven strategy combining R&D and industrialization, the company is anchored in research capabilities while targeting scalable production. By tailoring solutions to diverse client needs, Caremo delivers customized R&D and industrialization strategies that bridge scientific innovation with market-ready outcomes.
New Drug Preclinical Research Platform
Caremo is committed to delivering one-stop preclinical research services for global pharmaceutical and biotech companies. The company has established multiple preclinical research platforms for new drug development, with ongoing efforts to expand and refine its capabilities.
Protac protein degradation platform
Macrocyclic peptide platform
PDC drug R&D platform
In vivo and in vitro pharmacology evaluation platform
Follow us
Contract Us：
Add：Building C6, No. 9, Weidi Road, Qixia District, Nanjing
P.C：210046
Tel：025-85760569
M.P：bd@caremo.com.cn
